Cullinan Therapeutics (CGEM) FCF Margin (2021)
Cullinan Therapeutics (CGEM) posted quarterly FCF Margin of 8.0% for Q1 2021.
Powered by 
Analysis
Cullinan Therapeutics (CGEM) FCF Margin (2021) Analysis & Trends
Cullinan Therapeutics' FCF Margin history runs 1 years deep, the most recent figure standing at 8.0% for Q1 2021.
- In Q1 2021, FCF Margin changed N/A year-over-year to 8.0%; the TTM figure through Dec 2021 stood at 229.28% (changed N/A YoY), while the FY2021 annual figure was 229.28%, changed N/A from the prior year.
- FCF Margin for Q1 2021 stood at 8.0%.
- The five-year high for FCF Margin was 8.0% in Q1 2021, with the low at 8.0% in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Cullinan Therapeutics | 1.37 Bn | 1.37 Bn | - | - |